(This page is under construction! Check often for updates)
NEW DRUGS/INDICATIONS APPROVED IN JAPAN (May – September 2014)
May 23, 2014
Imunomax-γ for Injection 50
Imunomax-γ for Injection 100
(Shionogi & Co., Ltd.)
[Orphan drug]
#
Ranmark Subcutaneous Injection 120 mg
(Daiichi Sankyo Company, Limited)
[Orphan drug]
#
Januvia Tablets 12.5 mg
Januvia Tablets 25 mg
Januvia Tablets 50 mg
Januvia Tablets 100 mg
(MSD K.K.)
#
Glactiv Tablets 12.5 mg
Glactiv Tablets 25 mg
Glactiv Tablets 50 mg
Glactiv Tablets 100 mg
(Ono Pharmaceutical Co., Ltd.)
#
Nesina Tablets 6.25 mg
Nesina Tablets 12.5 mg
Nesina Tablets 25 mg
(Takeda Pharmaceutical Company Limited)
#
Aredia for I.V. Infusion 15 mg
Aredia for I.V. Infusion 30 mg
(Novartis Pharma K.K.)
#
Vancomycin Hydrochloride for Intravenous
Drip Infusion 0.5 g
(Shionogi & Co., Ltd.)
June 20, 2014
Nexavar Tablets 200 mg
(Bayer Yakuhin, Ltd.)
[Orphan drug]
#
Fentos Tape 1 mg
Fentos Tape 2 mg
Fentos Tape 4 mg
Fentos Tape 6 mg
Fentos Tape 8 mg
(Hisamitsu Pharmaceutical Co., Inc.)
#
Feiba NF for Injection 500
Feiba NF for Injection 1000
(Baxter Limited)
#
Prevenar 13 Suspension Liquid for Injection
(Pfizer Japan Inc.)
#
Mirena 52 mg
(Bayer Yakuhin, Ltd.)
July 4
Canaglu Tablets 100 mg
(Mitsubishi Tanabe Pharma Corporation)
#
E Keppra for I.V. Infusion 500 mg
(UCB Japan Co., Ltd.)
#
Clenafin Topical Solution 10% for Nail
(Kaken Pharmaceutical Co., Ltd.)
#
Deltyba Tablets 50 mg
(Otsuka Pharmaceutical Co., Ltd.)
[Orphan drug]
#
Anoro Ellipta 7 doses
Anoro Ellipta 30 doses
(GlaxoSmithKline K.K.)
#
Zytiga Tablets 250 mg
(Janssen Pharmaceutical K.K.)
#
Jevtana 60 mg I.V. Infusion
(Sanofi K.K.)
#
Menactra Intramuscular Injection
(Sanofi K.K.)
#
Anaemetro Intravenous Infusion 500 mg
(Pfizer Japan Inc.)
#
Jakavi Tablets 5 mg
(Novartis Pharma K.K.)
[Orphan drug]
#
Alecensa Capsule 20 mg
Alecensa Capsule 40 mg
(Chugai Pharmaceutical Co., Ltd.)
[Orphan drug]
#
Byclot Combination Intravenous Injection
(Kaketsuken [The Chemo-Sero-Therapeutic Research Institute])
[Orphan drug]
#
Rapalimus Tablets 1 mg
(Nobelpharma Co., Ltd.)
[Orphan drug]
(to be continued)…